ERTAPENEM

Product NDC: 42023-221
Requested package NDC: 42023-221-10
11-digit product format: 420230221
Labeler code: 42023
Product ID: 42023-221_137f9963-a021-47a5-8bb0-2a1621030708
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: ertapenem sodium
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAMUSCULAR; INTRAVENOUS
Labeler: ENDO USA, Inc.
Application: NDA021337
Marketing category: NDA
Marketing start: 2018-11-01
Substance: ERTAPENEM SODIUM
Active strength: 1 g/1
Pharmacologic classes: Carbapenems [CS], Penem Antibacterial [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021337-001	INVANZ	ERTAPENEM SODIUM	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N021337-001	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021337-001	INVANZ	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	RLD, RS	2001-11-21	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021337-001	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021337-001	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021337-001	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021337-001	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021337-001	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021337-001	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021337-001	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021337-001	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021337-001	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021337-001	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021337-001	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021337-001	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021337-001	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021337-001	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021337-001	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021337-001	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021337-001	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021337-001	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021337-001	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021337-001	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021337-001	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021337-001	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021337-001	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021337-001	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021337-001	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021337-001	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021337-001	AP	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021337-001	AP	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021337-001	AP	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021337-001	AP	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021337-001	AP	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021337-001	AP	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021337-001	AP	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021337-001	AP	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021337-001	AP	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021337-001	AP	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021337-001	AP	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021337-001	AP	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021337-001	AP	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021337-001	AP	1	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: ERTAPENEM
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ERTAPENEM SODIUM	1 g/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2T90KE67L0	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1734683	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
41304b1d-7db4-468a-ab1d-04e56fb50de4	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
aa4e6ef0-aff8-b16d-a7b0-a1baf91ab629	Product name	6	20250623
fb7ab793-2c12-4079-b100-a64f73bef25a	Product name	4	20240712
b0cbf770-6cc3-4aa4-9158-755110c2b9f7	Product name	2	20230717
dc7c5daa-021f-40dd-b00d-63982cb2067a	Product name	1	20230426
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	5	20200925
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	2	20160823
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
42023-221-01	ERTAPENEM	1 in 1 VIAL, SINGLE-DOSE	INJECTION, POWDER, LYOPHILIZED,	1	13
42023-221-10	ERTAPENEM	10 in 1 PACKAGE	INJECTION, POWDER, LYOPHILIZED,	10	13
42023-221-85	ERTAPENEM	10 in 1 PACKAGE	INJECTION, POWDER, LYOPHILIZED,	10	13
42023-221-89	ERTAPENEM	1 in 1 VIAL, SINGLE-DOSE	INJECTION, POWDER, LYOPHILIZED,	1	13

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
42023-221-01	EA - Each	42023-221	ab48327d-4a9d-49ae-93cb-36b2e50be6f2	1	2018-08-13
42023-221-10	EA - Each	42023-221	5bce14c2-8926-4eb4-a8cc-2bba14d9ebd9	1	2018-08-13
42023-221-85	EA - Each	42023-221	cca54412-b1b8-4749-9c80-0c30149b3ec6	1	2018-12-13
42023-221-89	EA - Each	42023-221	014f44b1-2664-42fc-bdd2-c33f5769861b	1	2018-12-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
42023-221	ERTAPENEM (ERTAPENEM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ENDO USA, INC.]	10	Current NDC, Legacy NDC, 2 package rows	20240716_657855f2-7c92-4aa8-9c3d-51d08e56a09a.zip
42023-221	ERTAPENEM (ERTAPENEM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ENDO USA, INC.]	9	Current NDC, Legacy NDC, 2 package rows	20240716_41304b1d-7db4-468a-ab1d-04e56fb50de4.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ERTAPENEM	ERTAPENEM SODIUM	ENDO USA, Inc.	41304b1d-7db4-468a-ab1d-04e56fb50de4	2026-03-02	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021337 application number: NDA021337 ndc (product): 42023-221
ERTAPENEM	ERTAPENEM SODIUM	ENDO USA, Inc.	657855f2-7c92-4aa8-9c3d-51d08e56a09a	2026-03-02	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021337 application number: NDA021337 ndc (package): 42023-221-10 ndc (product): 42023-221 ndc11 (package): 42023022110
INVANZ	ERTAPENEM SODIUM	Merck Sharp & Dohme LLC	33f3b99b-fa82-42e0-26bf-f49891ae3d22	2026-02-04	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021337 application number: NDA021337

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
2T90KE67L0	ERTAPENEM SODIUM	153773-82-1	ERTAPENEM SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1734683	ertapenem sodium 1 GM Injection	PSN	41304b1d-7db4-468a-ab1d-04e56fb50de4	13
1734683	ertapenem sodium 1 GM Injection	PSN	657855f2-7c92-4aa8-9c3d-51d08e56a09a	13
1734683	ertapenem 1000 MG Injection	SCD	41304b1d-7db4-468a-ab1d-04e56fb50de4	13
1734683	ertapenem 1000 MG Injection	SCD	657855f2-7c92-4aa8-9c3d-51d08e56a09a	13
1734683	ertapenem (as ertapenem sodium 1.046 GM) Injection	SY	41304b1d-7db4-468a-ab1d-04e56fb50de4	13
1734683	ertapenem (as ertapenem sodium 1.046 GM) Injection	SY	657855f2-7c92-4aa8-9c3d-51d08e56a09a	13
1734683	ertapenem 1 GM Injection	SY	41304b1d-7db4-468a-ab1d-04e56fb50de4	13
1734683	ertapenem 1 GM Injection	SY	657855f2-7c92-4aa8-9c3d-51d08e56a09a	13

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
42023-221-10	42023022110	10 VIAL, SINGLE-DOSE in 1 PACKAGE (42023-221-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (42023-221-01)	2018-07-26	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ERTAPENEM	ENDO USA, Inc. \| Merck Sharp & Dohme LLC	2026-03-02	HUMAN PRESCRIPTION DRUG LABEL	13
ERTAPENEM	ENDO USA, Inc. \| Merck Sharp & Dohme LLC	2026-03-02	HUMAN PRESCRIPTION DRUG LABEL	13